Görkem Kurtuldu Sahin

Title: Görkem Kurtuldu Sahin: Innovator in Modified IL-2 Polypeptides

Introduction

Görkem Kurtuldu Sahin is a prominent inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of modified IL-2 polypeptides. His work focuses on innovative treatments for diseases, including cancer.

Latest Patents

Görkem Kurtuldu Sahin holds 1 patent for his invention titled "Modified IL-2 polypeptides and uses thereof." This patent encompasses modified IL-2 polypeptides, compositions that include these polypeptides, methods for their production, and their application in treating various diseases. Notably, his research highlights the potential of these modified IL-2 polypeptides in cancer treatment, showcasing their preferential binding to the IL-2 receptor βγ complex over the IL-2 receptor αβγ complex. Additionally, the molecular weight distribution of these polypeptides is characterized as monodispersed.

Career Highlights

Görkem Kurtuldu Sahin is associated with Bright Peak Therapeutics AG, where he continues to advance his research and development efforts. His innovative approach to biotechnology has positioned him as a key figure in the industry.

Collaborations

Görkem collaborates with notable professionals in his field, including Vijaya Raghavan Pattabiraman and Roberto Iacone. These collaborations enhance the scope and impact of his research.

Conclusion

Görkem Kurtuldu Sahin is a distinguished inventor whose work on modified IL-2 polypeptides is paving the way for new cancer treatments. His contributions to biotechnology are significant and continue to influence the field positively.